Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aripiprazole”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01123707
What this trial is testing

To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization, Inc. 173
Post-approval studies (Phase 4)Study completedNCT00277212
What this trial is testing

A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,169
Not applicableEnded earlyNCT02717130
What this trial is testing

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

Who this might be right for
Schizophrenia
Florida Atlantic University 9
Post-approval studies (Phase 4)Ended earlyNCT03661983
What this trial is testing

Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder

Who this might be right for
Tourette's Disorder (TD)
Otsuka Pharmaceutical Development & Commercialization, Inc. 36
Large-scale testing (Phase 3)Ended earlyNCT01111539
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization, Inc. 211
Early research (Phase 1)Study completedNCT03287505
What this trial is testing

Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Beijing Research Institute 24
Not applicableStudy completedNCT04812379
What this trial is testing

Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

Who this might be right for
Bipolar Disorder I
Otsuka Pharmaceutical Co., Ltd. 535
Post-approval studies (Phase 4)Study completedNCT02091882
What this trial is testing

Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)

Who this might be right for
Device Latency
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Large-scale testing (Phase 3)Study completedNCT00036127
What this trial is testing

Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc.
Large-scale testing (Phase 3)Study completedNCT00194077
What this trial is testing

Study of Aripiprazole (Abilify) in Children With Symptoms of Mania

Who this might be right for
Bipolar Disorder
University Hospitals Cleveland Medical Center 60
Not applicableEnded earlyNCT00209027
What this trial is testing

The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia

Who this might be right for
Schizophrenia
Emory University 20
Post-approval studies (Phase 4)Study completedNCT01157351
What this trial is testing

15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated

Who this might be right for
Schizophrenia
Janssen Scientific Affairs, LLC 450
Large-scale testing (Phase 3)Study completedNCT01683058
What this trial is testing

Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 74
Large-scale testing (Phase 3)Study completedNCT00870727
What this trial is testing

Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders

Who this might be right for
Pervasive Developmental Disorder
Indiana University 33
Not applicableStudy completedNCT01562808
What this trial is testing

Change in Brain Metabolism and Cognitive Function by Aripiprazole

Who this might be right for
AntipsychoticsCognitionBrain Metabolism+1 more
Seoul National University Hospital 15
Large-scale testing (Phase 3)Study completedNCT00095511
What this trial is testing

Aripiprazole in Patients With Acute Mania

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 615
Large-scale testing (Phase 3)Study completedNCT01469039
What this trial is testing

Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia

Who this might be right for
Schizophrenia
Alkermes, Inc. 623
Large-scale testing (Phase 3)Study completedNCT00606281
What this trial is testing

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 258
Not applicableEnded earlyNCT00211380
What this trial is testing

Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)

Who this might be right for
SchizophreniaSchizoaffective Disorder
Louisiana State University Health Sciences Center Shreveport 8
Not applicableStudy completedNCT06372210
What this trial is testing

A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

Who this might be right for
Mental DisorderSchizophreniaMajor Depressive Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 54
Next Page